The Global Anatomic Pathology Market finds applications in various areas of healthcare. It is utilized for the diagnosis and characterization of diseases, including cancer, infectious diseases, and autoimmune disorders. Anatomic pathology plays a crucial role in surgical pathology, cytopathology, autopsy pathology, and molecular pathology. It also contributes to research and drug development, providing insights into disease mechanisms and therapeutic targets.
According to Data Bridge Market Research, the global anatomic pathology market was valued at 18.66 billion in 2021 and is expected to reach the value of USD 31.70 billion by the year 2029, at a CAGR of 6.85% in the forecast period of 2022 to 2029.
“Rise in the cases of cancer facilitate market growth”
The rise in cases of cancer serves as a significant driver of the global anatomic pathology market. With an increasing incidence of cancer worldwide, there is a growing demand for accurate diagnosis, prognosis, and personalized treatment approaches. Anatomic pathology plays a critical role in cancer diagnostics by examining tissue samples and identifying abnormalities or malignancies. It provides valuable insights into tumor characteristics, staging, and molecular markers, aiding in treatment decisions. The rising burden of cancer, coupled with advancements in pathology techniques and technologies, drives the growth of the global anatomic pathology market as healthcare providers strive to improve cancer detection, management, and patient outcomes.
What restraints the growth of the global anatomic pathology market?
“Scarcity of refurbished anatomic pathology instruments”
The scarcity of refurbished anatomic pathology instruments serves as a significant restraint in the global anatomic pathology market. Refurbished instruments play a crucial role in providing cost-effective solutions for laboratories, especially in resource-constrained settings. However, the limited availability of refurbished instruments restricts the options for laboratories seeking affordable alternatives. This scarcity can result from factors such as the high demand for new instruments, limited supply of used instruments, and challenges in refurbishment processes. The lack of accessible refurbished instruments hinders the expansion and adoption of anatomic pathology services, particularly in regions with budgetary constraints and limited healthcare resources.
Segmentation: Global Anatomic Pathology Market
The anatomic pathology market is segmented on the basis of product and services, application, and end users.
- On the basis of product and services, the anatomic pathology market is segmented into instrument and consumables.
- On the basis of application, the anatomic pathology market is segmented into disease diagnosis, drug discovery and development, and other applications.
- On the basis of end users, the anatomic pathology market is segmented into pathology labs, research institutes, hospitals, and others.
Regional Insights: North America expected to dominate the Global Anatomic Pathology Market
North America holds the largest revenue share in the pathology market, primarily due to the presence of major players and supportive government initiatives for training pathological programs. The favorable reimbursement policies in the United States and the increasing adoption of tissue-diagnostic procedures for disease screening drive market growth in the region.
The Asia Pacific (APAC) market is witnessing significant expansion driven by the rising demand for advanced imaging modalities, improved patient care facilities, and the franchising of pathology laboratories. Public agencies in China, such as the Pathology Branch of the Chinese Medical Association, actively support pathology projects, contributing to the rapid growth of the APAC market. The region's increasing focus on healthcare infrastructure development and the establishment of pathology facilities further boosts market growth in APAC.
To know more about the study visit, https://www.databridgemarketresearch.com/fr/reports/global-anatomic-pathology-market
Recent Developments in Global Anatomic Pathology Market
- In May 2021, Hologic received FDA premarket approval (PMA) for its ThinPrep GenesisTM processor, enabling cytology processing and specimen transfer for downstream applications. The FDA approval signifies the system's efficacy and safety in handling cytology samples, providing healthcare professionals with advanced tools for accurate diagnostic testing and improving patient outcomes.
- In January 2019, PHC Holding Corporation completed the acquisition of Thermo Fisher Scientific's Anatomical Pathology business, solidifying its position in the diagnostics segment. The acquisition expanded PHC's portfolio of diagnostic products and solutions, enhancing its capabilities in anatomical pathology and strengthening its presence in the global diagnostics market.
The Prominent Key Players Operating in the Global Anatomic Pathology Market Include:
- F. Hoffmann-La Roche Ltd. (Switzerland)
- Mylan N.V. (U.S.)
- Teva Pharmaceutical Industries Ltd. (Israel)
- Sanofi (France)
- Pfizer Inc. (U.S.)
- GlaxoSmithKline plc (UK)
- Novartis AG (Switzerland)
- Bayer AG (Germany)
- Eli Lilly and Company (U.S.)
- Merck & Co., Inc. (U.S.)
- Allergan (Ireland)
- AstraZeneca (U.K.)
- Johnson & Johnson Private Limited (U.S.)
- Cipla Inc. (U.S.)
- Bausch Health Companies Inc. (Canada)
- Abbott (U.S.)
Above are the key players covered in the report, to know about more and exhaustive list of global anatomic pathology market companies contact, https://www.databridgemarketresearch.com/fr/contact
Research Methodology: Global Anatomic Pathology Market
Data collection and base year analysis are done using data collection modules with large sample sizes. The market data is analyzed and estimated using market statistical and coherent models. In addition, market share analysis and key trend analysis are the major success factors in the market report. The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, global vs Regional and Vendor Share Analysis. Please request analyst call in case of further inquiry.
